142 related articles for article (PubMed ID: 37545140)
21. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.
Kye BH; Kim HJ; Kim G; Kim JG; Cho HM
Cancer Res Treat; 2016 Apr; 48(2):561-6. PubMed ID: 26323642
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation.
van den Broek JJ; van der Wolf FS; Lahaye MJ; Heijnen LA; Meischl C; Heitbrink MA; Schreurs WH
Dis Colon Rectum; 2017 Mar; 60(3):274-283. PubMed ID: 28177989
[TBL] [Abstract][Full Text] [Related]
23. T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
Hayes IP; Milanzi E; Pelly RM; Gibbs P; Reece JC
J Surg Oncol; 2022 Sep; 126(4):728-739. PubMed ID: 35635190
[TBL] [Abstract][Full Text] [Related]
24. Correlative Significance of Tumor Regression Grade and ypT Category in Patients Undergoing Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
Ryu HS; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JH; Kim JC
Clin Colorectal Cancer; 2022 Sep; 21(3):212-219. PubMed ID: 35300935
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
[TBL] [Abstract][Full Text] [Related]
26. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
[TBL] [Abstract][Full Text] [Related]
27. [Neoadjuvant treatment as a limiting factor to rectal ultrasonography].
Fábián A; Bor R; Bálint A; Farkas K; Milassin Á; Rutka M; Tiszlavicz L; Nagy F; Molnár T; Szepes Z
Orv Hetil; 2016 Jul; 157(30):1193-7. PubMed ID: 27452069
[TBL] [Abstract][Full Text] [Related]
28. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
[TBL] [Abstract][Full Text] [Related]
29. How reliable is restaging MRI after neoadjuvant therapy in rectal cancer?
Gefen R; Garoufalia Z; Horesh N; Freund MR; Emile SH; Parlade A; Berho M; Allende D; DaSilva G; Wexner SD
Colorectal Dis; 2023 Aug; 25(8):1631-1637. PubMed ID: 37376824
[TBL] [Abstract][Full Text] [Related]
30. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy.
Bhoday J; Smith F; Siddiqui MR; Balyasnikova S; Swift RI; Perez R; Habr-Gama A; Brown G
Dis Colon Rectum; 2016 Oct; 59(10):925-33. PubMed ID: 27602923
[TBL] [Abstract][Full Text] [Related]
32. Rectal MRI Interpretation After Neoadjuvant Therapy.
Horvat N; El Homsi M; Miranda J; Mazaheri Y; Gollub MJ; Paroder V
J Magn Reson Imaging; 2023 Feb; 57(2):353-369. PubMed ID: 36073323
[TBL] [Abstract][Full Text] [Related]
33. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.
Lambregts DMJ; van Heeswijk MM; Delli Pizzi A; van Elderen SGC; Andrade L; Peters NHGM; Kint PAM; Osinga-de Jong M; Bipat S; Ooms R; Lahaye MJ; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
Eur Radiol; 2017 Oct; 27(10):4445-4454. PubMed ID: 28409357
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery.
2017 European Society of Coloproctology (ESCP) collaborating group
Colorectal Dis; 2018 Sep; 20 Suppl 6():58-68. PubMed ID: 30255641
[TBL] [Abstract][Full Text] [Related]
36. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
[TBL] [Abstract][Full Text] [Related]
37. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
[TBL] [Abstract][Full Text] [Related]
38. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy.
Arslan A; Akay E; Turk G; Eren SK
J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728
[TBL] [Abstract][Full Text] [Related]
40. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
